Switch theme
Sign up to access all valuation multiples
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
2001
104.2K+
LTM Revenue $180B
LTM EBITDA $11.1B
$123B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Elevance Health has a last 12-month revenue of $180B and a last 12-month EBITDA of $11.1B.
In the most recent fiscal year, Elevance Health achieved revenue of $177B and an EBITDA of n/a.
Elevance Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Elevance Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $171B | $177B | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | n/a | n/a | XXX | XXX | XXX |
| EBITDA Margin | NaN% | NaN% | XXX | XXX | XXX |
| Net Profit | $6.0B | $6.0B | XXX | XXX | XXX |
| Net Margin | 4% | 3% | XXX | XXX | XXX |
| Net Debt | $16.7B | $18.6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Elevance Health's stock price is $441.
Elevance Health has current market cap of $99.9B, and EV of $123B.
See Elevance Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $123B | $99.9B | XXX | XXX | XXX | XXX | $33.47 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Elevance Health has market cap of $99.9B and EV of $123B.
Elevance Health's trades at 0.7x LTM EV/Revenue multiple, and 11.1x LTM EBITDA.
Analysts estimate Elevance Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Elevance Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $123B | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | 16.7x | XXX | XXX | XXX |
| P/E/Growth | 0.9x | XXX | XXX | XXX |
| EV/FCF | 27.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpElevance Health's NTM/LTM revenue growth is 9%
Elevance Health's revenue per employee for the last fiscal year averaged $1.7M, while opex per employee averaged n/a for the same period.
Over next 12 months, Elevance Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Elevance Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Elevance Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.7M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| ADNIC | XXX | XXX | XXX | XXX | XXX | XXX |
| Aegon | XXX | XXX | XXX | XXX | XXX | XXX |
| ASR Nederland | XXX | XXX | XXX | XXX | XXX | XXX |
| NN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Challenger | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Elevance Health acquired XXX companies to date.
Last acquisition by Elevance Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Elevance Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Elevance Health founded? | Elevance Health was founded in 2001. |
| Where is Elevance Health headquartered? | Elevance Health is headquartered in United States of America. |
| How many employees does Elevance Health have? | As of today, Elevance Health has 104.2K+ employees. |
| Who is the CEO of Elevance Health? | Elevance Health's CEO is Ms. Gail Koziara Boudreaux. |
| Is Elevance Health publicy listed? | Yes, Elevance Health is a public company listed on NYS. |
| What is the stock symbol of Elevance Health? | Elevance Health trades under ELV ticker. |
| When did Elevance Health go public? | Elevance Health went public in 2001. |
| Who are competitors of Elevance Health? | Similar companies to Elevance Health include e.g. ADNIC, Aegon, ASR Nederland, NN Group. |
| What is the current market cap of Elevance Health? | Elevance Health's current market cap is $99.9B |
| What is the current revenue of Elevance Health? | Elevance Health's last 12-month revenue is $180B. |
| What is the current EBITDA of Elevance Health? | Elevance Health's last 12-month EBITDA is $11.1B. |
| What is the current EV/Revenue multiple of Elevance Health? | Current revenue multiple of Elevance Health is 0.7x. |
| What is the current EV/EBITDA multiple of Elevance Health? | Current EBITDA multiple of Elevance Health is 11.1x. |
| What is the current revenue growth of Elevance Health? | Elevance Health revenue growth between 2023 and 2024 was 3%. |
| Is Elevance Health profitable? | Yes, Elevance Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
